2018
Hemoglobin A1c Targets for Glycemic Control With Pharmacologic Therapy for Nonpregnant Adults With Type 2 Diabetes Mellitus: A Guidance Statement Update From the American College of Physicians.
Qaseem A, Wilt T, Kansagara D, Horwitch C, Barry M, Forciea M, Fitterman N, Balzer K, Boyd C, Humphrey L, Iorio A, Lin J, Maroto M, McLean R, Mustafa R, Tufte J. Hemoglobin A1c Targets for Glycemic Control With Pharmacologic Therapy for Nonpregnant Adults With Type 2 Diabetes Mellitus: A Guidance Statement Update From the American College of Physicians. Annals Of Internal Medicine 2018, 168: 569-576. PMID: 29507945, DOI: 10.7326/m17-0939.Peer-Reviewed Original ResearchMeSH KeywordsAdultBlood GlucoseDiabetes Mellitus, Type 2FemaleGlycated HemoglobinHumansMalePractice Guidelines as TopicUnited StatesConceptsType 2 diabetesAmerican CollegePharmacologic therapyGlycemic controlGeneral healthScottish Intercollegiate Guidelines NetworkGuidelines International Network libraryClinical Systems ImprovementHemoglobin A1c targetPatient's general healthAmerican Diabetes AssociationAGREE II instrumentLife expectancyNational Guideline ClearinghouseCost of careA1C targetsNonpregnant adultsMost patientsPharmacologic treatmentClinical EndocrinologistsTreatment burdenDiabetes AssociationPatient preferencesChronic conditionsAdvanced age
2017
Oral Pharmacologic Treatment of Type 2 Diabetes Mellitus: A Clinical Practice Guideline Update From the American College of Physicians.
Qaseem A, Barry M, Humphrey L, Forciea M, Fitterman N, Horwitch C, Kansagara D, McLean R, Wilt T. Oral Pharmacologic Treatment of Type 2 Diabetes Mellitus: A Clinical Practice Guideline Update From the American College of Physicians. Annals Of Internal Medicine 2017, 166: 279-290. PMID: 28055075, DOI: 10.7326/m16-1860.Peer-Reviewed Original ResearchConceptsType 2 diabetesOral pharmacologic treatmentGlycemic controlPharmacologic treatmentPatient populationAmerican CollegeSodium-glucose cotransporter 2 inhibitorsType 2Clinical Practice Guideline UpdateDipeptidyl peptidase-4 inhibitorsCotransporter 2 inhibitorsSGLT-2 inhibitorsSystolic blood pressurePeptidase-4 inhibitorsDPP-4 inhibitorsTarget patient populationTotality of evidenceACP guidelinesCerebrovascular morbidityCause mortalityOral medicationsOral therapyPharmacologic therapyBlood pressureHemoglobin A1c